A cross-sectional study of patients with and without substance use disorders in Community Mental Health Centres

BMC Psychiatry

Volumn 11, Issue , 2011, Pages

  Wüsthoff, Linda E ^a   Waal, Helge ^a   Ruud, Torleif ^a,b   Gråwe, Rolf W ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c Dept of Research and Development at the Alcohol and Drug Treatment Health Trust in Central Norway ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; COMMUNITY MENTAL HEALTH CENTER; CONVALESCENCE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH SERVICE; MOOD DISORDER; MORBIDITY; NORWAY; OUTPATIENT CARE; PERSONALITY DISORDER; PREVALENCE; PSYCHOSIS; RATING SCALE; RURAL AREA; SUBSTANCE ABUSE; URBAN AREA;

EID: 79956200596     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-11-93     Document Type: Article

References (46)

1. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264:2511-2518. 10.1001/jama.264.19.2511, 2232018.
2. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 1996, 66:17-31.
3. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Aguilar-Gaziola S, Bijl R, Borges G, Caraveo-Anduaga JJ, DeWit DJ, Kolody B, Vega WA, Wittchen HU, Kessler RC. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav 1998, 23:893-907. 10.1016/S0306-4603(98)00076-8, 9801724.
4. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. [References]. Archives of General Psychiatry 2007, 64(7):830-842. 10.1001/archpsyc.64.7.830, 17606817.
5. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. [References]. Archives of General Psychiatry 2007, 64(5):566-576. 10.1001/archpsyc.64.5.566, 17485608.
6. Breakey WR, Fischer PJ, Kramer M, Nestadt G, Romanoski AJ, Ross A, Royall RM, Stine OC. Health and Mental-Health Problems of Homeless Men and Women in Baltimore. Jama-Journal of the American Medical Association 1989, 262:1352-1357.
7. Flovig JC, Vaaler AE, Morken G. Substance use at admission to an acute psychiatric department. [References]. Nordic Journal of Psychiatry 2009, 63:113-119. 10.1080/08039480802294787, 18991157.
8. Helseth V, Lykke-Enger T, Johnsen J, Waal H. Substance use disorders among psychotic patients admitted to inpatient psychiatric care. Nord J Psychiatry 2009, 63:72-77. 10.1080/08039480802450439, 19034727.
9. Weaver T, Rutter D, Madden P, Ward J, Stimson G, Renton A. Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough. Soc Psychiatry Psychiatr Epidemiol 2001, 36:399-406. 10.1007/s001270170030, 11766970.
10. Ananth J, Vandewater S, Kamal M, Brodsky A. Missed diagnosis of substance abuse in psychiatric patients. Hospital & Community Psychiatry 1989, 40:297-299.
11. Hansen SS, Munk-Jorgensen P, Guldbaek B, Solgard T, Lauszus KS, Albrechtsen N, Borg L, Egander A, Faurholdt K, Gilberg A, Gosden NP, Lorenzen J, Richelsen B, Weischer K, Bertelsen A. Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand 2000, 102:432-438. 10.1034/j.1600-0447.2000.102006432.x, 11142432.
12. Gogek EB. Prevalence of substance abuse in psychiatric patients. Am J Psychiatry 1991, 148:1086.
13. Harris KM, Edlund MJ. Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatr Serv 2005, 56:954-959. 10.1176/appi.ps.56.8.954, 16088012.
14. World Health Organization ICD-10: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. 1992, World Health Organization.
15. Wusthoff LE, Waal H, Ruud T, Roislien J, Grawe RW. Identifying co-occurring substance use disorders in community mental health centres. Tailored approaches are needed. Nord J Psychiatry 2011, 65:58-64. 10.3109/08039488.2010.489954, 20507263.
16. Ruud T, Reas D. Community Mental Health Centres, health services and patient satisfaction: Status and variation 2002. 2003, SINTEF Unimed, STF78 A035008 [Norwegian].
17. Grawe RW, Hatling T, Ruud T. Does the development of Community Mental Health Centres contribute to better health services and higher patient satisfaction? Results from investigations conducted in 2002, 2005 and 2007. Revised report [Norwegian]. 25-9-2008. SINTEF Helse 7465 Trondheim. Rapport nr SINTEF A 6169.
18. Wing JK, Beevor AS, Curtis RH, Park SB, Hadden S, Burns A. Health of the Nation Outcome Scales (HoNOS). Research and development. Br J Psychiatry 1998, 172:11-18. 10.1192/bjp.172.1.11, 9534825.
19. Wing J, Curtis RH, Beevor A. Health of the Nation Outcome Scales (HoNOS) - Glossary for HoNOS score sheet. Br J Psychiatry 1999, 174:432-434. 10.1192/bjp.174.5.432, 10616611.
20. Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS. Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990, 16:57-67.
21. Mueser KT, Drake RE, Clark RE, McHugo GJ, Mercer-McFadden C, Ackerson TH. A toolkit for evaluating substance abuse in persons with severe mental illness. Cambridge, MA: the Evaluation Center@HSRI 1995,
22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174. 10.2307/2529310, 843571.
23. Fleiss JL, Cohen J. The Equivalence of Weighted Kappa and the Intraclass Correlation Coefficient as Measures of Reliability. Educational and Psychological Measurement 1973, 33:613-619.
24. SPSS for Windows, Rel. 18.0.3. 2010. 2010, Chicago: SPSS Inc.
25. Cohen JW. Statistical power analyses for the behavioral sciences. 1988, Hillsdale, NJ: Lawrence Erlbaum Associates, 2.
26. Kringlen E, Torgersen S, Cramer V. A Norwegian psychiatric epidemiological study. [References]. Am J Psychiatry 2001, 158:1091-1098. 10.1176/appi.ajp.158.7.1091, 11431231.
27. Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 1990, 16:31-56.
28. Bonsack C, Camus D, Kaufmann N, Aubert AC, Besson J, Baumann P, Borgeat F, Gillet M, Eap CB. Prevalence of substance use in a Swiss psychiatric hospital: Interview reports and urine screening. [References]. Addict Behav 2006, 31:1252-1258. 10.1016/j.addbeh.2005.08.008, 16137835.
29. Ford L, Snowden LR, Walser EJ. Outpatient mental health and the dual-diagnosis patient: Utilization of services and community adjustment. Eval Program Plann 1991, 291-298.
30. Naeem F, Kingdon D, Turkington D. Cognitive behaviour therapy for Schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy 2005, 34:207-215. 10.1080/16506070510010684, 16498749.
31. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale--preliminary report. Psychopharmacol Bull 1973, 9:13-28.
32. Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 1976, 128:280-289. 10.1192/bjp.128.3.280, 1252693.
33. Derogatis LR. The SCL-90 Manual I: Scoring, administration and procedures for the SCL-90. 1977, Baltimore: Johns Hopkins University School of Medicine, Clinical Psychometrics Unit.
34. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998, 24:443-455.
35. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. [References]. Arch Gen Psychiatry 2007, 64:830-842. 10.1001/archpsyc.64.7.830, 17606817.
36. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. [References]. Arch Gen Psychiatry 2007, 64:566-576. 10.1001/archpsyc.64.5.566, 17485608.
37. Bakken K, Landheim AS, Vaglum P. Axis I and II disorders as long-term predictors of mental distress: a six-year prospective follow-up of substance-dependent patients. BMC Psychiatry 2007, 7:29. 10.1186/1471-244X-7-29, 1914057, 17594479.
38. Deans C, Soar R. Caring for clients with dual diagnosis in rural communities in Australia: The experience of mental health professionals. [References]. J Psychiatr Ment Health Nurs 2005, 268-274.
39. Lehman AF, Steinwachs DM. Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophr Bull 1998, 24:11-20.
40. Moser LL, Deluca NL, Bond GR, Rollins AL. Implementing evidence-based psychosocial practices: lessons learned from statewide implementation of two practices. CNS Spectr 2004, 9:926-36. 942.
41. Baker KD, Lubman DI, Cosgrave EM, Killackey EJ, Yuen HP, Hides L, Baksheev GN, Buckby JA, Yung AR. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment. [References]. Aust N Z J Psychiatry 2007, 896-902.
42. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction 1993, 88:791-804. 10.1111/j.1360-0443.1993.tb02093.x, 8329970.
43. Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res 2005, 11:22-31. 10.1159/000081413, 15608468.
44. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). 2002, New York: Biometrics Research, New York State Psychiatric Institute.
45. Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry 1996, 153:1195-1201.
46. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980, 168:26-33. 10.1097/00005053-198001000-00006, 7351540.